These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28797289)

  • 1. Insulin resistance and associated factors among HIV-infected patients in sub-Saharan Africa: a cross sectional study from Cameroon.
    Noumegni SRN; Nansseu JR; Ama VJM; Bigna JJ; Assah FK; Guewo-Fokeng M; Leumi S; Katte JC; Dehayem M; Kengne AP; Sobngwi E
    Lipids Health Dis; 2017 Aug; 16(1):148. PubMed ID: 28797289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fasting blood glucose and insulin sensitivity are unaffected by HAART duration in Cameroonians receiving first-line antiretroviral treatment.
    Ekali LG; Johnstone LK; Echouffo-Tcheugui JB; Kouanfack C; Dehayem MY; Fezeu L; Nouthe B; Hayes L; Unwin NC; Sobngwi E
    Diabetes Metab; 2013 Feb; 39(1):71-7. PubMed ID: 23153435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiometabolic risk factors among HIV patients on antiretroviral therapy.
    Kiage JN; Heimburger DC; Nyirenda CK; Wellons MF; Bagchi S; Chi BH; Koethe JR; Arnett DK; Kabagambe EK
    Lipids Health Dis; 2013 Apr; 12():50. PubMed ID: 23575345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lipid profile of HIV-infected patients receiving antiretroviral therapy in a rural Cameroonian population.
    Bekolo CE; Nguena MB; Ewane L; Bekoule PS; Kollo B
    BMC Public Health; 2014 Mar; 14():236. PubMed ID: 24606888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly active antiretroviral therapy and dyslipidemia in people living with HIV/AIDS in Fako Division, South West Region of Cameroon.
    Nsagha DS; Weledji EP; Assob NJ; Njunda LA; Tanue EA; Kibu OD; Ayima CW; Ngowe MN
    BMC Cardiovasc Disord; 2015 Aug; 15():95. PubMed ID: 26315756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of dyslipidaemia among HIV-infected patients receiving combination antiretroviral therapy in North Shewa, Ethiopia.
    Fiseha T; Alemu W; Dereje H; Tamir Z; Gebreweld A
    PLoS One; 2021; 16(4):e0250328. PubMed ID: 33905435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral treatment associated hyperglycemia and dyslipidemia among HIV infected patients at Burayu Health Center, Addis Ababa, Ethiopia: a cross-sectional comparative study.
    Abebe M; Kinde S; Belay G; Gebreegziabxier A; Challa F; Gebeyehu T; Nigussie P; Tegbaru B
    BMC Res Notes; 2014 Jun; 7():380. PubMed ID: 24950924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Obesity, high blood pressure, hypercholesterolaemia, and untreated diabetes in HIV-infected and HIV-uninfected Adults in Mbuji-Mayi (Democratic republic of congo)].
    Mukeba-Tshialala D; Nachega JB; Mutombo-Tshingwali M; Arendt V; Gilson G; Moutschen M
    Bull Soc Pathol Exot; 2017 Dec; 110(5):301-309. PubMed ID: 28623554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Prevalence of Dyslipidemia and Insulin Resistance in HIV-infected Prepubertal African Children on Antiretroviral Therapy.
    Innes S; Abdullah KL; Haubrich R; Cotton MF; Browne SH
    Pediatr Infect Dis J; 2016 Jan; 35(1):e1-7. PubMed ID: 26421804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic Syndrome Among Antiretroviral Therapy-Naive Versus Experienced HIV-Infected Patients Without Preexisting Cardiometabolic Disorders in Western Kenya.
    Osoti A; Temu TM; Kirui N; Ngetich EK; Kamano JH; Page S; Farquhar C; Bloomfield GS
    AIDS Patient Care STDS; 2018 Jun; 32(6):215-222. PubMed ID: 29851503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High correlation between Framingham equations with BMI and with lipids to estimate cardiovascular risks score at baseline in HIV-infected adults in the Temprano trial, ANRS 12136 in Côte d'Ivoire.
    Ghehi C; Gabillard D; Moh R; Badje A; Kouamé GM; Oouttara E; Ahibo H; N'Takpé JB; Lecarrou J; Eholié SP; Anglaret X; Danel C
    PLoS One; 2017; 12(6):e0177440. PubMed ID: 28582393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.
    Ciaffi L; Koulla-Shiro S; Sawadogo AB; Ndour CT; Eymard-Duvernay S; Mbouyap PR; Ayangma L; Zoungrana J; Gueye NFN; Diallo M; Izard S; Bado G; Kane CT; Aghokeng AF; Peeters M; Girard PM; Le Moing V; Reynes J; Delaporte E;
    Lancet HIV; 2017 Sep; 4(9):e384-e392. PubMed ID: 28566227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Spirulina platensis supplementation on lipid profile in HIV-infected antiretroviral naïve patients in Yaounde-Cameroon: a randomized trial study.
    Ngo-Matip ME; Pieme CA; Azabji-Kenfack M; Biapa PC; Germaine N; Heike E; Moukette BM; Emmanuel K; Philippe S; Mbofung CM; Ngogang JY
    Lipids Health Dis; 2014 Dec; 13():191. PubMed ID: 25496727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for HIV-associated neurocognitive disorders (HAND) in sub-Saharan Africa: the case of Yaoundé-Cameroon.
    Njamnshi AK; Bissek AC; Ongolo-Zogo P; Tabah EN; Lekoubou AZ; Yepnjio FN; Fonsah JY; Kuate CT; Angwafor SA; Dema F; Njamnshi DM; Kouanfack C; Djientcheu Vde P; Muna WF; Kanmogne GD
    J Neurol Sci; 2009 Oct; 285(1-2):149-53. PubMed ID: 19631349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.
    Meis SB; Schuster D; Gaillard T; Osei K
    Ethn Dis; 2006; 16(4):830-6. PubMed ID: 17061734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The burden of hypertension, diabetes mellitus, and cardiovascular risk factors among adult Malawians in HIV care: consequences for integrated services.
    Divala OH; Amberbir A; Ismail Z; Beyene T; Garone D; Pfaff C; Singano V; Akello H; Joshua M; Nyirenda MJ; Matengeni A; Berman J; Mallewa J; Chinomba GS; Kayange N; Allain TJ; Chan AK; Sodhi SK; van Oosterhout JJ
    BMC Public Health; 2016 Dec; 16(1):1243. PubMed ID: 27955664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparison of the Diabetes Risk Score in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) and HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon.
    Dimala CA; Atashili J; Mbuagbaw JC; Wilfred A; Monekosso GL
    PLoS One; 2016; 11(5):e0155560. PubMed ID: 27195956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in lipid profile over 24 months among adults on first-line highly active antiretroviral therapy in the home-based AIDS care program in rural Uganda.
    Buchacz K; Weidle PJ; Moore D; Were W; Mermin J; Downing R; Kigozi A; Borkowf CB; Ndazima V; Brooks JT
    J Acquir Immune Defic Syndr; 2008 Mar; 47(3):304-11. PubMed ID: 18398971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coprevalence and associations of diabetes mellitus and hypertension among people living with HIV/AIDS in Cameroon.
    Ebasone PV; Dzudie A; Peer N; Hoover D; Shi Q; Kim HY; Brazier E; Ajeh R; Yotebieng M; Nash D; Anastos K; Kengne AP
    AIDS Res Ther; 2024 Jun; 21(1):36. PubMed ID: 38824579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.
    Soria A; Porten K; Fampou-Toundji JC; Galli L; Mougnutou R; Buard V; Kfutwah A; Vessière A; Rousset D; Teck R; Calmy A; Ciaffi L; Lazzarin A; Gianotti N
    Antivir Ther; 2009; 14(3):339-47. PubMed ID: 19474468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.